Neurophysiologic Study on Effects of Sativex(R) on Spasticity in Progressive Multiple Sclerosis.
Phase of Trial: Phase III
Latest Information Update: 13 Sep 2014
At a glance
- Drugs Nabiximols (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms NS-MSS
- Sponsors Almirall S.A.
- 17 Jan 2014 Status changed from recruiting to completed as reported by the ClinicalTrials.gov record.
- 21 Aug 2013 Planned End Date changed from 1 Apr 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 24 Jan 2013 Planned End Date changed from 1 Nov 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.